Moderna stock surges more than doubled
Statements (26)
- Bullish
Moderna stock reached a new all-time high.
- Bullish
Moderna stock jumped
- Bullish
Moderna stock more than doubled in a month
- Bullish
Moderna's stock price rose 6% on Thursday
- Bullish
Moderna's stock closed at $174.38 on August 19, 2026, a single-session gain of 176.9%.
- Bullish
Moderna's stock price is likely to rise significantly as the company pivots to cancer research following the decline in vaccine demand.
- Bullish
Moderna's stock price rose 177% following a shift to focus on cancer company operations.
- Bearish
Moderna shares dropped 15% in premarket trading
- Bearish
Moderna Inc. shares are likely to continue declining after its historic rally, as the company's positive announcements from competitors may dampen investor confidence.
- Bullish
Moderna's stock rose 177% to $174
- Bullish
Moderna stock surges more than doubled on Wednesday morning
- Bullish
Moderna's cancer vaccine breakthrough drives biopharma stock rally
- Bullish
Moderna shares jumped 144% in the afternoon session
- Bullish
Moderna shares rallied dramatically
- Bullish
Moderna could be the first S&P 500 stock since 2008 to double in a day
- Bullish
Moderna stock shares more than doubled on Wednesday morning
- Bullish
Moderna shares more than doubled on Wednesday, adding about $30 billion to its market value
- Bullish
Moderna stock surges more than doubled on Wednesday morning
- Bullish
Moderna stock rose 93% to $121.76 in early Wednesday trading
- Bullish
Moderna (MRNA) surged on the stock market
- Bullish
Moderna jumped premarket after Phase 3 trial results were announced
- Bullish
Moderna stock price rose over 60% on Wednesday
- Bullish
Moderna's cancer breakthrough stock soared
- Bullish
Moderna shares rose 44.2% to $63.36 following its Q2 earnings.
- Bullish
Moderna stock has already gained 83% in 2026
- Neutral
Moderna reported Q1 earnings results compared to other therapeutics stocks